Tucker Joseph's most recent trade in Enveric Biosciences Inc was a trade of 161,633 Common Stock done . Disclosure was reported to the exchange on Oct. 9, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Enveric Biosciences Inc | Tucker Joseph | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 161,633 | 335,829 (10%) | 5% | 0 | Common Stock | |
Enveric Biosciences Inc | Tucker Joseph | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 100,000 | 174,196 (5%) | 3% | 0 | Common Stock | |
Enveric Biosciences Inc | Joseph Tucker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 44,000 | 74,196 (2%) | 1% | 0 | Common Stock | |
Enveric Biosciences Inc | Joseph Tucker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 15,000 | 30,196 (0%) | 0% | 0 | Common Stock | |
Enveric Biosciences Inc | Joseph Tucker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 1,374 | 15,196 (0%) | 0% | 0 | Common Stock | |
Enveric Biosciences Inc | Joseph Tucker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 691,083 | 691,083 (22%) | 22% | - | Common Stock | |
Enveric Biosciences Inc | Joseph Tucker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 531,602 | 531,602 | - | - | Common Warrants | |
Enveric Biosciences Inc | Joseph Tucker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 132,901 | 132,901 | - | - | Common Warrants | |
Enveric Biosciences Inc | Joseph Tucker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 13,290 | 13,290 | - | - | Common Warrants |